Table 4 Comparison of IgG4-related thyroiditis in this study with Non-IgG4 related thyroiditis of HT in previous study
From: Clinical features and treatment efficacy for IgG4-related thyroiditis
Demographic features | Our study IgG4-related thyroiditis | Li’s study [16] Non-IgG4 thyroiditis in HT | Li’s study [9] Non-IgG4 thyroiditis in HT | P value |
|---|---|---|---|---|
Sample size | 14 | 51 | 93 | NA |
Age (years) | 42.8 ± 14.9 | 57.7 ± 8.6 | 58.12 ± 10.05 | NA |
Disease duration(yr) | 4.1 ± 4.0 | 17.11 ± 10.34 | 14.88 ± 10.13 | NA |
Male/Female ratio | 1:1 | 1:16 | 5:88 | 0.036* |
Tg-Ab (Normal upper limit multiple) | 27.58 ± 13.18 | 3.53 ± 6.79 | 1.73 (0.92–3.24) | NA |
TPO-Ab (Normal upper limit multiple) | 13.97 ± 4.78 | 2.55 ± 7.42 | 0.94 (0.60–1. 46) | NA |
Thyroid functional status (subclinical hypo-/eu-/subclinical hyper-) | 13/1/0 | 5/36/8 | 10/61/12 |  < 0.001* |